With Cuban pharmacies empty, regime boasts biopharmaceutical advances with China
AREQUIPA, Peru – The Cuban regime is preparing clinical trials of the monoclonal antibody Itolizumab in China. Currently, the joint venture Cuba-China Biotech Pharmaceuticals Limited (BPL) is preparing to work with the